Immuno-Oncology Business Development and Strategic Alliances

NanoString Technologies
Job Location
San Francisco, 94114

Medical, dental, 401k, stock options, ESPP

Job Description


Reporting to the Senior Vice President of Corporate and Business Development, the Immuno-Oncology Business Development & Strategic Alliances role will serve as a key member of the Corporate and Business Development team, working closely with cross functional partners and the executive management team to drive and implement the Immuno-Oncology strategy.

Working with members of the cross-functional team, this position will play a leading role in shaping and refining the Immuno-Oncology strategic plan, will be the point person to coordinate company-wide activity related to Immuno-Oncology and will nurture relationships & manage the subsequent business development process / alliance management with academia, biopharmaceutical companies, associations and institutions. 

Essential Duties:

  • Lead biopharma partnering activities in the field of Immuno-Oncology.
  • Manage collaboration with Merck focused on development of predictive assay for KEYTRUDA.
  • Coordinate company-wide activity related to Immuno-Oncology.
  • In conjunction with team, develop and refine the strategic plan to capitalize on the immuno-oncology opportunity, including the research and diagnostic product roadmap and partnering approach.
  • Develop an understanding of the relevant disease biology, influential KOLs, disease management, new and emerging tools & diagnostics and new and emerging therapeutics in the field of Immuno-Oncology.
  • Identify, develop and nurture scientific and business IO relationships within academia, biopharmaceutical companies, associations, institutions and other stakeholders.
  • In conjunction with evaluation team, prioritize and access best-in-class IO content as basis for new research use only products and diagnostic assays.
  • Enter value-creating IO collaborations with premiere biopharmaceutical companies and leading KOLs/academics by applying best-practices across the business development process including:
  • Discover and prioritize potential collaboration opportunities by actively prospecting, collaborating with cross-functional partners and leveraging your network.
  • Oversee and conduct robust analysis and due diligence to uncover and advance the highest potential opportunities.
  • Construct innovative, value-creating “win-win” deals to meet strategic and financial goals, and effectively negotiate successful outcomes.
  • Develop and champion the business case and strategic rationale with Senior Management.
  • Take a leadership role in driving IO collaboration implementation.
  • Be a proactive and inspirational advocate for NanoString. Establish and build IO network to generate NanoString visibility and leadership.
  • Core contributor to Corporate & Business Development team to ensure individual and departmental goals are achieved by providing leadership, team support and driving other key initiatives.


  • Minimum of advanced degree in science or medicine; MBA preferred.
  • Energetic, resourceful self-starter with high integrity, strong executive presence and the ability to work effectively in a dynamic, entrepreneurial environment.
  • Excellent analytical, project management and organizational skills with the ability to make sound business judgments.
  • Solid network with demonstrated capability to build and maintain trusted relationships with shared vision and commitment to action.
  • Track record of driving from inception to execution including valuation, diligence, deal engineering and leading negotiations with particular emphasis with pursuing and closing “sell side” value-creating deals with biopharmaceutical companies.
  • Strong scientific, technical and business acumen in oncology (including solid tumors & hematological within immuno-oncology), personalized medicine, therapeutics and molecular diagnostics.
  • A strategic thinker with outstanding business instincts who can help chart the course and translate into actionable, value-creating results for the company.
  • An ability to embrace teamwork and collaboration.
  • Ability and willingness to travel.
About Our Organization

NanoString Technologies is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection, and in 2013 launched Prosigna, its first in vitro diagnostic product for prognosis of early stage breast cancer.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.

A new survey from the Pew Research Center finds that half of women working in STEM have experienced gender discrimination at work.

A proposal to tax students' tuition waivers no longer appears in the US tax bill, Vox reports.